1 / 1

More than 80 companies currently claim to offer manufacturing related services / By Roots Analysis

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their respective capacities, mostly through acquisitions, in order to gain a competitive edge.<br><br>To order this 300 page report, which features 140 figures and 190 tables, please visit this - https://www.rootsanalysis.com/reports/view_document/oligonucleotide-synthesis/304.html<br>Contact Details<br>Gaurav Chaudhary<br> 1 (415) 800 3415<br>gaurav.chaudhary@rootsanalysis.com<br><br>

kevin987
Download Presentation

More than 80 companies currently claim to offer manufacturing related services / By Roots Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related